Takatsuki, Japan

Akira Kakizuka

This inventor holds 6 USPTO granted patents and 4 EPO patents. Top assignees: Kyoto University, Daito Chemix Corporation, Other. Active years: 1998-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Akira Kakizuka. Retrieved from https://idiyas.com/inventor/akira-kakizuka

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 2.9

ph-index = 2

Forward Citations = 12(Granted Patents)


Location History:

  • Kan'yuchi, Uji-shi, Kyoto, JP (1998)
  • Takatsuki, JP (2017 - 2018)
  • Kyoto, JP (2015 - 2024)

Company Filing History:

goldMedal5 out of 871 
 
Kyoto University
 patents
silverMedal2 out of 7 
 
Daito Chemix Corporation
 patents
bronzeMedal1 out of 834,570 
Other
 patents
where one patent can have more than one assignee

Years Active: 1998-2024

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Akira Kakizuka: Innovator in Cardiovascular and Metabolic Health

Introduction

Akira Kakizuka, a prominent inventor based in Takatsuki, Japan, has made significant contributions to the fields of cardiovascular and metabolic health through his innovative research and patents. With a total of six patents to his name, Kakizuka's work addresses critical health issues, particularly those related to cardiomyocyte protection and leptin resistance.

Latest Patents

Among his latest innovative patents is a pharmaceutical composition designed for protecting cardiomyocytes. The invention outlines the use of specific compounds that may safeguard cardiac cells from degeneration, particularly in conditions such as myocardial infarction, chronic heart failure, hypertensive heart failure, and dilated cardiomyopathy. This breakthrough holds the potential for improving treatment outcomes for patients suffering from heart ailments.

Another notable patent focuses on improving leptin resistance, a key factor in various metabolic disorders. This invention comprises a compound that enhances the body's response to leptin, alongside methods for producing pharmaceuticals that utilize this compound. The implications of this patent are vast, as it may aid in addressing metabolic disorders such as obesity, diabetes, and dyslipidemia.

Career Highlights

Kakizuka has been affiliated with esteemed institutions, notably Kyoto University and Daito Chemix Corporation. His role in these organizations has allowed him not only to advance his research but also to contribute valuable insights into drug development and applications in pharmaceutical sciences.

Collaborations

Throughout his career, Akira Kakizuka has engaged in fruitful collaborations with notable coworkers, including Seiji Hori and Toshiyuki Shudo. These partnerships have fostered a rich exchange of ideas and expertise, further propelling advancements in their respective fields.

Conclusion

In conclusion, Akira Kakizuka stands out as an influential inventor whose patents reflect a deep commitment to enhancing human health. His work on cardiomyocyte protection and leptin resistance not only showcases his innovative spirit but also has the potential to significantly impact the medical community and improve patient outcomes across various conditions. As research in these areas continues, Kakizuka's contributions are expected to play a crucial role in the future of therapeutic developments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…